SpyGlass Pharma SGP
NASDAQ SGP
$27.40 +1.24 (+4.74%)
As of: Oct 21, 2026 · 2:42 PM EDT

SpyGlass Pharma (SGP) Common Equity (2024 - 2026)

Updated

SpyGlass Pharma's Common Equity was $232.36 million in Q2 2026, compared with -$78.38 million a year earlier.

Analysis

SpyGlass Pharma (SGP) Common Equity (2024 - 2026) Analysis & Trends

At the end of FY2025, Common Equity at SpyGlass Pharma came in at -$98.84 million.

  • In earlier years, Common Equity was -$60.47 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Eli Lilly 1,136.92 Bn 1,105.50 Bn 19.71 Bn 33.88 Bn
2 Johnson & Johnson 617.57 Bn 536.10 Bn 17.26 Bn 84.97 Bn
3 AbbVie 501.37 Bn 474.48 Bn 12.70 Bn -5.94 Bn
4 Merck 367.96 Bn 322.33 Bn 12.21 Bn 41.98 Bn
5 Novartis Ag 297.98 Bn 261.97 Bn 11.24 Bn 41.95 Bn
6 Astrazeneca 261.45 Bn 235.14 Bn 12.86 Bn 50.37 Bn
7 Amgen 236.30 Bn 191.70 Bn 7.24 Bn 11.69 Bn
8 Gilead Sciences 190.27 Bn 164.46 Bn 6.22 Bn 11.83 Bn
9 Pfizer 169.65 Bn 116.29 Bn 10.94 Bn 85.49 Bn
10 SpyGlass Pharma 916.24 Mn 916.24 Mn - 232.36 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 232.36 Mn
Dec 31, 2025 -98.84 Mn
Jun 30, 2025 -78.38 Mn
Dec 31, 2024 -60.47 Mn
API Access

SpyGlass Pharma Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=SGP&period=max&api_key=YOUR_API_KEY